HLB Panagene Co., Ltd. (KOSDAQ: A046210)
Health Care · Biotechnology · KR
₩1,400.00
-21.08% today · -15.6% 1Y
HLB Panagene Co., Ltd. (KOSDAQ: A046210) operates in the Biotechnology industry within the Health Care sector. The company is valued at $47.81M.
Over the last twelve months the share price has lost 15.6%, trading between 980.00 and 2.94K.
Tweenvest scores HLB Panagene Co., Ltd. across four factors: quality 68/100, value 50/100. Its strongest factor is quality.
A046210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $47.81M
- Revenue (TTM)
- $9.50M
- P/E
- —
- EPS
- -71.46
- Dividend yield
- —
- Beta (5Y)
- -0.21
- 52-week high
- ₩2,940.00
- 52-week low
- ₩980.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.53M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Optipharm.CO.,LTDKOSDAQ: A153710 | $48.80M | ₩4,435.00 | -1.22% |
| GENINUS Inc.KOSDAQ: A389030 | $48.75M | ₩1,650.00 | -15.38% |
| Connect Biopharma Holdings LimitedNasdaqGM: CNTB | $48.27M | $0.77 | +0.58% |
| MiNK Therapeutics, Inc.NasdaqCM: INKT | $48.02M | $9.41 | -12.22% |
| Sangamo Therapeutics, Inc.OTCPK: SGMO.Q | $47.64M | $0.12 | +9.52% |
| Werewolf Therapeutics, Inc.NasdaqCM: HOWL | $47.63M | $0.98 | +0.04% |
| Kalaris Therapeutics, Inc.NasdaqGM: KLRS | $47.61M | $2.00 | -15.25% |
| 2invest AGDB: 2INV | $47.49M | €7.68 | -3.52% |
Figures last refreshed Oct 18, 2026.